{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:20:58Z","timestamp":1764134458740,"version":"3.46.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a long-term, immune-mediated inflammatory disorder of the skin, affecting about 2-3% of the global population with rising prevalence rates. Clinical practice has demonstrated that Fuzhenghefuzhiyang formula (FZHFZY), a topical medication applied Chinese herbal formula developed by Prof. Lu Chuanjian, exhibits significant efficacy in alleviating psoriasis symptoms. Nevertheless, its mechanism of anti-psoriasis remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The purpose of this study is to decode the molecular mechanisms by which FZHFZY produces its therapeutic effects on psoriasis using an integrated multi-omics approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Employing both cell-based and animal studies, we systematically elucidate the pharmacodynamic substance basis and biological pathways underlying its anti-psoriasis effects by integrating network pharmacology to predict the active ingredient-target network, metabolomics to analyze endogenous metabolite changes, and transcriptome sequencing to dissect gene expression regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FZHFZY effectively alleviated symptoms of skin thickening, erythema, and scaling in psoriatic model mice. Network pharmacology predicted that its therapeutic effect might be related to target pathways associated with inflammation, metabolism, proliferation, pyroptosis. RNA sequencing analysis of skin lesion tissues revealed that FZHFZY modulated the inflammation-related NOD-like receptor (NLR) and IL-17 signaling pathways. Further validation by RT-PCR showed that FZHFZY markedly downregulated the mRNA levels of IL-17 and NLRP3. Metabolomics analysis of the lesion tissues identified 169 differential metabolites, and FZHFZY was found to regulate the catabolism of carbohydrates, purines, and most amino acids. Cross-analysis of the two omics approaches indicated that purine metabolism and ether lipid metabolism were associated with key genes in the NLR signaling pathway identified by MCODE analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed that FZHFZY can effectively improve lesion conditions in a psoriasis-like mouse model, and its mechanism of action may be related to the association between purine metabolism, lipid metabolism, and key genes in the NLR signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1690070","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:15:52Z","timestamp":1764134152000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Bin","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangliang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.01.014","article-title":"From empirical to pathogenesis-based treatments for psoriasis","volume":"142","author":"Van de Kerkhof","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jep.2022.115275","article-title":"Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis","author":"Li","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-022-3683-8","article-title":"Chinese medicine as supporting therapy for psoriasis: past, present, and future","volume":"29","author":"Yang Xueyuan","year":"2023","journal-title":"Chin J Integr Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.563433","article-title":"Chinese medicine formula PSORI-CM02 alleviates psoriatic dermatitis via M-MDSCs and th17 crosstalk","volume":"11","author":"Deng","year":"2021","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.749626","article-title":"A traditional chinese medicine formula danshen baibixiao ameliorates imiquimod-induced psoriasis-like inflammation in mice","volume":"12","author":"Jin","year":"2021","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112246","article-title":"Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation","volume":"246","author":"Chao Chih","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0297834","DOI":"10.1371\/journal.pone.0297834","article-title":"Add-on effects of Chinese herbal medicine external application (FZHFZY) to topical urea for mild-to-moderate psoriasis vulgaris: Protocol for a double-blinded randomized controlled pilot trial embedded with a qualitative study","volume":"19","author":"Junyue","year":"2024","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113331","article-title":"Decoding active components in a formulation of multiple herbs for treatment of psoriasis based on three cell lines fishing and liquid chromatography-mass spectrometry analysis","volume":"186","author":"Chen","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3969\/i.issn.1001-1528.2025.08.010","article-title":"Mechanistic investigation of Fuzheng Hefu Zhiyang Formula in alleviatingpsoriasis inflammatory microenvironment via P38\/Erk\/NF-kB signalingpathway","volume":"47","author":"Liao","year":"2025","journal-title":"Chin Traditional Patent Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.650816","article-title":"Fuzhenghefuzhiyang formula (FZHFZY) improves epidermal differentiation via suppression of the akt\/mTORC1\/S6K1 signalling pathway in psoriatic models","volume":"12","author":"Lu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01767","article-title":"PSORI-CM02 formula increases CD4+Foxp3+Regulatory T cell frequency and ameliorates imiquimod-induced psoriasis in mice","volume":"8","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114622","article-title":"Physalis alkekengi L. var. franchetii combined with hormone therapy for atopic dermatitis","volume":"162","author":"Yang","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.27044\/d.cnki.ggzzu.2021.000258","article-title":"A retrospective and experimental study of Fuzheng Hefu Formula in the treatment of psoriasis vulgaris","author":"Mo","year":"2021","journal-title":"Guangzhou Univ Chin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz933","article-title":"Xenbase: deep integration of GEO & SRA RNA-seq and ChIP-seq data in a model organism database","volume":"48","author":"Fortriede","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 Inflammasome and Inflammatory Bowel Disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/exd.15135","article-title":"Pyroptosis and its role in autoimmune skin disease","volume":"7","author":"Yao","year":"2024","journal-title":"Exp Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2023.06.007","article-title":"Potential roles of inflammasomes in the pathophysiology of Psoriasis: A comprehensive review","volume":"161","author":"Shahi","year":"2023","journal-title":"Mol Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190388","article-title":"Aberrant inflammasome activation as a driving force of human autoimmune skin disease","volume":"14","author":"Fetter","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1038\/s41467-024-53396-x","article-title":"Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy","volume":"15","author":"Surve","year":"2024","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065653","article-title":"Cornus officinalis seed extract inhibits AIM2-inflammasome activation and attenuates imiquimod-induced psoriasis-like skin inflammation","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2024.70.4.13","article-title":"Effects of silencing NLRP3 gene on proliferation of psoriasis-like HaCaT cells and expressions of cytokines","volume":"70","author":"An","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-Grand France)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102614","article-title":"Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities","volume":"118","author":"Srivastava","year":"2021","journal-title":"J Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/2040622318759282","article-title":"Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment","volume":"9","author":"Chan Tom","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00150-5","article-title":"naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation","volume":"25","author":"Bork","year":"2024","journal-title":"EMBO Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2018.06.001","article-title":"Integrative methylome and transcriptome analysis to dissect key biological pathways for psoriasis in Chinese Han population","volume":"91","author":"Tang","year":"2018","journal-title":"J Dermatol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14529","article-title":"A systematic review: metabolomics-based identification of altered metabolites and pathways in the skin caused by internal and external factors","volume":"31","author":"Masutin","year":"2022","journal-title":"Exp Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2021.0465","article-title":"Integrated metabolomics and transcriptomics analyses reveal histidine metabolism plays an important role in imiquimod-induced psoriasis-like skin inflammation","volume":"40","author":"Wu","year":"2021","journal-title":"DNA Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737573","article-title":"Hyperuricemia in psoriatic arthritis: epidemiology, pathophysiology, and clinical implications","volume":"8","author":"Tripolino","year":"2021","journal-title":"Front Med"},{"key":"B31","first-page":"3","article-title":"Metabolism of purine compounds in psoriasis","author":"Tikhonov Iu","year":"1998","journal-title":"Klinicheskaia Laboratornaia Diagn"},{"key":"B32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/pr.113.008540","article-title":"The A3 adenosine receptor: history and perspectives","volume":"67","author":"Borea","year":"2015","journal-title":"Pharmacol Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24352-w","article-title":"The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7150\/thno.89180","article-title":"Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles","volume":"14","author":"Jiang","year":"2024","journal-title":"Theranostics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-018-0505-z","article-title":"IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis","volume":"9","author":"Hou","year":"2018","journal-title":"Protein Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00567-7","article-title":"USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1690070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:15:54Z","timestamp":1764134154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1690070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2025.1690070"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1690070","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1690070"}}